We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-0.6%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$44.1B
AUM Growth
-$1.93B
(-4.2%)
Cap. Flow
-$863M
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
24.82%
Holding
984
New
120
Increased
284
Reduced
350
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$192M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$151M |
| 3 |
Dover
DOV
|
+$127M |
| 4 |
Honeywell
HON
|
+$123M |
| 5 |
Chevron
CVX
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$282M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$180M |
| 3 |
Johnson Controls International
JCI
|
+$172M |
| 4 |
Lockheed Martin
LMT
|
+$160M |
| 5 |
Republic Services
RSG
|
+$143M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.68% |
| 2 | Healthcare | 17.44% |
| 3 | Financials | 11.47% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
VF Corp
VFC
$5.8B
| $1.39M | ﹤0.01% |
78,600
-250,500
| -76% | -$4.77M |
|
752
Arq
ARQ
$90.6M
| $1.33M | ﹤0.01% |
750,000
| – | – |
|
|
CYPH
753
Cypherpunk Technologies Inc
CYPH
$71.7M
| $1.3M | ﹤0.01% |
942,918
| – | – |
|
754
SentinelOne
S
$7.12B
| $1.26M | ﹤0.01% |
+75,000
| New | +$1.18M |
|
755
COPT Defense Properties
CDP
$4.22B
| $1.25M | ﹤0.01% |
+52,398
| New | +$1.32M |
|
|
THRD
756
DELISTED
Third Harmonic Bio
THRD
| $1.23M | ﹤0.01% |
+192,027
| New | +$1.17M |
|
757
Neurogene
NGNE
$710M
| $1.22M | ﹤0.01% |
+77,500
| New | +$1.14M |
|
758
Caribou Biosciences
CRBU
$163M
| $1.21M | ﹤0.01% |
253,933
| – | – |
|
759
On Holding
ONON
$12.4B
| $1.2M | ﹤0.01% |
+43,000
| New | +$1.36M |
|
760
BP
BP
$109B
| $1.16M | ﹤0.01% |
+30,000
| New | +$1.11M |
|
761
ProPetro Holding
PUMP
$1.34B
| $1.06M | ﹤0.01% |
100,000
| – | – |
|
|
MREO
762
Mereo BioPharma
MREO
$48.8M
| $1.03M | ﹤0.01% |
+800,000
| New | +$1.06M |
|
|
SLRN
763
DELISTED
ACELYRIN
SLRN
| $1.02M | ﹤0.01% |
100,000
-270,000
| -73% | -$5.73M |
|
764
Rhythm Pharmaceuticals
RYTM
$7.72B
| $1M | ﹤0.01% |
+43,815
| New | +$981K |
|
765
CervoMed
CRVO
$25.6M
| $921K | ﹤0.01% |
+199,347
| New | +$1M |
|
766
Aligos Therapeutics
ALGS
$34.1M
| $914K | ﹤0.01% |
48,931
| – | – |
|
767
Moog Inc Class A
MOG.A
$13B
| $853K | ﹤0.01% |
7,553
| – | – |
|
768
Rezolute
RZLT
$453M
| $834K | ﹤0.01% |
631,690
| – | – |
|
769
Revolution Medicines
RVMD
$42.1B
| $830K | ﹤0.01% |
+30,000
| New | +$890K |
|
770
Liquidia Corp
LQDA
$7.95B
| $789K | ﹤0.01% |
124,478
-675,522
| -84% | -$4.87M |
|
771
Rapid Micro Biosystems
RPID
$104M
| $756K | ﹤0.01% |
700,000
| – | – |
|
772
Acuity Brands
AYI
$10.7B
| $679K | ﹤0.01% |
+3,989
| New | +$651K |
|
|
FARM
773
DELISTED
Farmer Brothers
FARM
| $648K | ﹤0.01% |
251,229
| – | – |
|
|
GIFI
774
DELISTED
Gulf Island Fabrication
GIFI
| $601K | ﹤0.01% |
183,877
| – | – |
|
775
Benitec Biopharma
BNTC
$451M
| $572K | ﹤0.01% |
+189,188
| New | +$588K |
|
Similar funds
Adage Capital Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Adage Capital Partners held 984 positions worth $44.1B, down 4.2% from $46B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners's Q3 2023 filing shows 120 new, 284 increased, 350 reduced and 125 closed positions. Its largest new stake was Blackstone: 705,700 shares worth $75.6M. The largest sale was Boeing, an estimated $282M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q3 2023 buy was Blackstone: 705,700 shares worth $75.6M.
- Adage Capital Partners added most to Emerson Electric in Q3 2023, an estimated $192M increase.
- Adage Capital Partners's biggest Q3 2023 reduction was Boeing, cutting an estimated $282M.
- Adage Capital Partners fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $180M.
- Adage Capital Partners's ten largest holdings make up 25% of its $44.1B portfolio in Q3 2023.
- Adage Capital Partners opened 120 new positions and closed 125 in Q3 2023.
- Adage Capital Partners's portfolio value fell 4.2% quarter-over-quarter to $44.1B.
Based on Adage Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.